APA (7th ed.) Citation

EA, G., JS, M., WN, L., JC, Y., Y, P., KJ, M., & D, D. (2024). Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study. Health and quality of life outcomes, 22(1), 62. https://doi.org/10.1186/s12955-024-02279-2

Chicago Style (17th ed.) Citation

EA, Griffiths, Min JS, Lee WN, Yu JC, Patel Y, Myren KJ, and Dingli D. "Patient-reported Outcomes and Daily Activity Assessed with a Digital Wearable Device in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: REVEAL, a Prospective, Observational Study." Health and Quality of Life Outcomes 22, no. 1 (2024): 62. https://doi.org/10.1186/s12955-024-02279-2.

MLA (9th ed.) Citation

EA, Griffiths, et al. "Patient-reported Outcomes and Daily Activity Assessed with a Digital Wearable Device in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: REVEAL, a Prospective, Observational Study." Health and Quality of Life Outcomes, vol. 22, no. 1, 2024, p. 62, https://doi.org/10.1186/s12955-024-02279-2.